Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
20 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Cibus, Inc.’s names, not what it holds today.
Patents granted
20
18 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 2 in 2023
Applications published
47
1 of them in 2025
Names they are printed under
6
a subsidiary, a former name, its own name
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
CIBUS US LLC a subsidiary
US, as the owner printed on each patent
18 granted
26 publishedCalyxt, Inc. a former name
US, as the owner printed on each patent
1 granted
8 publishedCalyxt, Inc. a former name
named as the applicant on its applications, in US
0 granted
6 publishedCIBUS EUROPE B.V. a subsidiary
named as the applicant on its applications, in NL
0 granted
5 publishedCibus, Inc. its own name
US, as the owner printed on each patent
1 granted
1 publishedCIBUS US LLC a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jun 17, 2025 | 12,331,303 | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | Biotechnology | CIBUS US LLC |
| Nov 26, 2024 | D1,052,452 | Plant shade | | Cibus, Inc. |
| Sep 19, 2023 | 11,761,011 | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | Biotechnology | CIBUS US LLC |
| Jan 3, 2023 | 11,542,515 | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | Biotechnology | CIBUS US LLC |
| Sep 6, 2022 | 11,434,494 | Targeted gene modification using oligonucleotide-mediated gene repair | Biotechnology | CIBUS US LLC |
| Aug 23, 2022 | 11,421,240 | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | Biotechnology | CIBUS US LLC |
| Jun 14, 2022 | 11,359,208 | Shatterproof genes and mutations | Biotechnology | CIBUS US LLC |
| Nov 2, 2021 | 11,160,224 | Non-transgenic herbicide resistant plants | Biotechnology | CIBUS US LLC |
| Sep 7, 2021 | 11,111,500 | Mutated protoporphyrinogen IX oxidase (PPX) genes | Biotechnology | CIBUS US LLC |
| Jul 27, 2021 | D926,077 | Plant separator | | Calyxt, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Feb 27, 2025 | 2025/0066805 | METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR | Biotechnology | CIBUS US LLC |
| Nov 14, 2024 | 2024/0376484 | TRANSFORMING CANNABACEAE CELLS | Biotechnology | CIBUS US LLC |
| Oct 10, 2024 | 2024/0336931 | SHATTERPROOF GENES AND MUTATIONS | Biotechnology | CIBUS US LLC |
| Aug 22, 2024 | 2024/0279669 | GRAFTED PLANT FOR DELIVERY OF GENOME EDITING REAGENTS | Biotechnology | CIBUS US LLC |
| Jun 20, 2024 | 2024/0200043 | TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS FUSED TO INTEINS | Biotechnology | Calyxt, Inc. |
| Jun 13, 2024 | 2024/0191245 | PLANT CELL MATRICES AND METHODS THEREOF | Biotechnology | Calyxt, Inc. |
| Mar 14, 2024 | 2024/0084316 | METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR | Biotechnology | CIBUS US LLC |
| Dec 21, 2023 | 2023/0407323 | DELIVERY OF GENOME EDITING REAGENTS VIA CHIMERIC PLANTS | Biotechnology | Calyxt, Inc. |
| Dec 21, 2023 | 2023/0407322 | METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR | Biotechnology | CIBUS US LLC |
| Oct 5, 2023 | 2023/0313211 | METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR | Biotechnology | CIBUS US LLC · patent 12,331,303 granted from it |
What it applied for, 2024 to 2025: Biotechnology 7.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.